Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home News

Key Biden agency dropped $60K on overseas conference with DEI workshop: ‘Should never happen’

admin by admin
May 15, 2025
in News
0
Key Biden agency dropped $60K on overseas conference with DEI workshop: ‘Should never happen’
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

A government watchdog has uncovered that former President Joe Biden’s Food and Drug Administration (FDA) spent tens of thousands of taxpayer dollars sending top officials to a conference in Scotland that included diversity, equity and inclusion (DEI) workshops.

The Functional Government Initiative (FGI), via a FOIA request, discovered that the Biden FDA spent an estimated $60,000 on a dozen staffers, including Senior Advisor for Health Equity Dr. Charlene Le Fauve, to attend the Society for Research on Nicotine and Tobacco’s (SRNT’s) conference in Edinburgh, Scotland, in March 2024.

While at the conference, members of the team attended a workshop that focused on the ‘stigma’ facing LGBTQ+ people in the field of tobacco research. 

Topics included in that workshop, according to the FDA’s own report on the trip, included ‘how anti-LGBTQ+ legislation and discriminatory and stigmatizing environments toward LGBTQ+ populations impact tobacco use and tobacco control research’ and ‘process to develop a community-based participatory research project to address smoking cessation among transgender individuals in Argentina.’

Another topic discussed was ‘the challenges of conducting research on tobacco use in the high-stigma environment of pregnancy in a post-Dobbs era.’

Le Fauve justified the trip, in part, by claiming ‘the knowledge gained at the meeting is critical to attendees’ ability to understand emerging scientific issues that may impact their work and their ability to effectively move forward agency initiatives.’

‘The formal SRNT conference included many sessions where health equity was an identified focus and I attended several which were highly relevant, well done, and informative including the Presidential Symposium that included three presenters supporting the premise that in order to have a global impact on the tobacco smoking pandemic, nicotine and tobacco research must broaden its vision beyond wealthy countries to include research and researchers in low and middle-income countries (LMICs), where the vast majority of the world’s people who smoke live,’ Le Fauve added. 

Also present on the trip was Center for Tobacco Products Director Brian King, who was recently relieved of his duty by the Trump administration in a move that a former agency official told Fox News Digital was a result of the FDA straying from its core mission under the Biden administration and focusing on issues like DEI.

‘There were many, many failures in the key core missions for the center that needed dramatic change in new leadership,’ David Oliveira, who recently left the FDA after six years, told Fox News Digital last month, explaining that the FDA was ceding responsibility to other departments and not doing enough to crackdown on China flooding the market with illicit vapes.

FGI Communications Director Roderick Law told Fox News Digital in a statement that spending tens of thousands of dollars to send a dozen employees to a conference in Scotland is another example of the agency losing focus on its mission. 

‘I, like anyone else in the world, would love to have a $60,000 vacation paid for by my employer,’ Law said.

‘Sadly, this dream became reality for 12 people on the taxpayer’s back. How can a group of government officials spend $60,000 on an LGBTQ+ workshop? How is it possible that this trip helped the agency stop illegal Chinese-made products or process applications for new products that could provide for harm reduction? This kind of waste should never happen again.’

Fox News Digital reached out to the FDA for comment.

This post appeared first on FOX NEWS

Previous Post

Republicans urge Trump to follow through on his plan to dismantle Iran’s nuclear capabilities

Next Post

SoFi stock price technical analysis points to a 30% surge

Next Post
SoFi stock price technical analysis points to a 30% surge

SoFi stock price technical analysis points to a 30% surge

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
CDC eyes narrower COVID-19 vaccine guidance ahead of 2025–2026 season

CDC eyes narrower COVID-19 vaccine guidance ahead of 2025–2026 season

April 15, 2025
Trump wants Apple to shift iPhone production from India to the US: here’s what it means

Trump wants Apple to shift iPhone production from India to the US: here’s what it means

0
Retail sales slumped 0.9% in January, down much more than expected

Retail sales slumped 0.9% in January, down much more than expected

0
Denny’s set to close dozens more locations this year, though some openings planned too

Denny’s set to close dozens more locations this year, though some openings planned too

0
Amazon ‘anti-union propaganda,’ employee surveillance loom over labor vote at North Carolina warehouse

Amazon ‘anti-union propaganda,’ employee surveillance loom over labor vote at North Carolina warehouse

0
Trump wants Apple to shift iPhone production from India to the US: here’s what it means

Trump wants Apple to shift iPhone production from India to the US: here’s what it means

May 16, 2025
Abu Dhabi’s Mubadala boosts Bitcoin ETF stake to $408.5M despite Q1 slump

Abu Dhabi’s Mubadala boosts Bitcoin ETF stake to $408.5M despite Q1 slump

May 16, 2025
Estee Lauder stock price analysis: rebound can’t be ruled out

Estee Lauder stock price analysis: rebound can’t be ruled out

May 16, 2025
Asian markets close: Nikkei flat as Japan’s GDP contracts; Sensex dips 200 pts

Asian markets close: Nikkei flat as Japan’s GDP contracts; Sensex dips 200 pts

May 16, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Trump wants Apple to shift iPhone production from India to the US: here’s what it means

    Trump wants Apple to shift iPhone production from India to the US: here’s what it means

    May 16, 2025
    Abu Dhabi’s Mubadala boosts Bitcoin ETF stake to $408.5M despite Q1 slump

    Abu Dhabi’s Mubadala boosts Bitcoin ETF stake to $408.5M despite Q1 slump

    May 16, 2025
    Estee Lauder stock price analysis: rebound can’t be ruled out

    Estee Lauder stock price analysis: rebound can’t be ruled out

    May 16, 2025
    Asian markets close: Nikkei flat as Japan’s GDP contracts; Sensex dips 200 pts

    Asian markets close: Nikkei flat as Japan’s GDP contracts; Sensex dips 200 pts

    May 16, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved